Table 1.

Baseline characteristics of the study populations in T1D and T2D

	Type 1 diabetes (n = 131)	Type 2 diabetes (n = 176)
Age (years)	42.37 ± 16.81 [11, 81]	62.82 ± 11.31 [34, 92]
Duration of diabetes	16.34 ± 13.31 [1, 60]	14.20 ± 8.55 [1, 52]
HbA1c (% ± SE)	8.15 ± 0.15	7.76 ± 0.12
Insulin therapy (% of patients)
CSII	12.2%	0%
MDI*	87.8%	100%

Age and duration of diabetes are presented as the mean ± standard deviation (SD) with the range in square brackets

SE standard error of the mean, CSII continuous subcutaneous insulin infusion, MDI multiple daily injections with insulin, T1D type 1 diabetes, T2D type 2 diabetes

*Patients on a variety of injection therapies, including mealtime only and basal bolus insulin therapy